From Spreadsheet to Bedside: Operationalizing an essential medication list

June 25, 2026

Participants will learn the purpose, structure, and intended use of an essential medication list and how to identify key operational strategies for implementing an EML. They will also learn to evaluate opportunities and challenges associated with integrating an essential medication list.

Target Audience

  • Pharmacists
  • Pharmacy Technicians
  • Other Healthcare Professionals

Learning Objectives

At the conclusion of this activity, participants should be able to:  

 

1)    Describe the purpose, structure, and intended use of an essential medication list in supporting medication shortage preparedness and continuity of patient care.
2)    Identify key operational strategies (ex. medication acuity scoring) for implementing an essential medication list across pharmacy, supply chain, and clinical teams to improve inventory management and shortage mitigation efforts.
3)    Evaluate opportunities and challenges associated with integrating an essential medication list into organizational workflows, policies, and decision-making processes.

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Course opens: 
06/25/2026
Course expires: 
08/24/2026
Event starts: 
06/25/2026 - 1:00pm CDT
Event ends: 
06/25/2026 - 2:00pm CDT
Add to calendar: 
Live Activity
United States
FACULTY & PLANNERS

Planners
Stacy Lauderdale, PharmD, BCPS
Associate Vice President of Evidence-Based Medicine and Drug Information
Vizient Inc.

Kyle Hoelting, PharmD, BCPS
Director
Pharmacy Supply Assurance & Stewardship
Vizient

Rebecca Easterwood 
CE Programs Manager               
Vizient, Inc. 

Marilu Kelly, MSN, RN, NPD-BC, CHCP 
Director, Continuing Education        
Vizient, Inc.

Faculty
David Aguero, PharmD, MSTL, FASHP, FAMIA
Director, Medication Systems and Informatics
St. Jude Children’s Research Hospital

Kyle Hoelting, PharmD, BCPS
Director
Pharmacy Supply Assurance & Stewardship
Vizient

 
 
DISCLOSURE
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
 
 
Statement of Content Validity
 
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Usage Disclosure: “Off-label/unapproved drug uses or products are mentioned within this activity.”
 
Evidence-based Content: “Low/absence of evidence-based topics are mentioned within this activity.”
 
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.
Disclosure Statements
 
Absence of Relevant Financial Relationships
 
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
Relevant Financial Relationships
Vizient, Inc., Jointly Accredited for Interprofessional Continuing Education, defines companies to be ineligible as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
An individual is considered to have a relevant financial relationship if the educational content an individual can control is related to the business lines or products of the ineligible company.
All relevant financial relationships listed for these individual(s) have been mitigated.
All others in a position to control content for this educational activity have no relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

 

 

Joint Accreditation Statement

In support of improving patient care, Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

 

 
Designation Statement(s)
 

Pharmacists (CPE)

 
Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for pharmacists.
 
Universal Activity Number:  JA0006103-0000-26-035-L04-P
 
Pharmacy Technicians (CPE)
 
Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for pharmacy technicians.
 
Universal Activity Number:  JA0006103-0000-26-035-L04-T
 
Other Healthcare Professionals (General CE Credit)
 
Vizient, Inc. will award all other healthcare professionals who successfully complete the activity a Certificate of Participation. Various state license boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
  • 1.00 General CE - Attendance
Please login or register to take this course.

 

Select the “Obtain Credit” button to access the activity evaluation and to claim CE Credit.
 
Please Note: 
  • If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
  • This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.
Please click here to enter the code you received at the end of the activity to verify your attendance if you have not already done so: https://continuingeducation.vizientinc.com/code

 

 

Required Hardware/software

 

The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.